Rozanolixizumab
Product Specifications
CAS Number
1584645-37-3
Target
Others, TNF
Related Pathways
Apoptosis, Others
Purity
0.972
Bioactivity
Rozanolixizumab (RYSTIGGO) is a high-affinity humanized immunoglobulin G4 monoclonal antibody targeting Fc receptors (FcRn) in human newborns for the study of pathogenic IgG in autoimmune and alloimmune diseases.
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog